CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Wuchterl Donald A. Director | Grant or award | +36,101 | 150,612 | ||
| 2025-01-31 | Crombez Eric Director | Grant or award | +36,101 | 47,145 | ||
| 2025-01-31 | Silverstein Christine Berni Director | Grant or award | +36,101 | 133,572 | ||
| 2025-01-31 | Charles Faith L. Director | Grant or award | +36,101 | 149,832 | ||
| 2025-01-31 | Amoroso Michael Director | Grant or award | +36,101 | 180,466 | ||
| 2025-01-31 | Alvino Mark Director | Grant or award | +36,101 | 100,435 | ||
| 2025-01-31 | Alland Leila Director | Grant or award | +36,101 | 154,366 | ||
| 2025-01-29 | Alvino Mark Director | Sale | −4,000 | $5.38 | $22K | 64,334 |
| 2025-01-21 | O'Malley Brendan M. SVP, General Counsel | Grant or award | +115,607 | 388,896 | ||
| 2025-01-21 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +144,509 | 509,726 | ||
| 2025-01-21 | Seshadri Vishwas Chief Executive Officer | Grant or award | +476,435 | 1,380,322 | ||
| 2025-01-21 | Alvino Mark Director | Sale | −4,000 | $5.10 | $20K | 68,334 |
| 2024-10-16 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −251 | $6.54 | $2K | 903,887 |
| 2024-09-28 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −18,798 | $5.89 | $111K | 904,138 |
| 2024-09-28 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −6,579 | $5.89 | $39K | 273,289 |
| 2024-09-28 | Vazzano Joseph Walter Chief Financial Officer | Shares withheld for taxes | −6,388 | $5.89 | $38K | 365,217 |
| 2024-09-20 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −496 | $6.02 | $3K | 279,868 |
| 2024-08-26 | Wuchterl Donald A. Director | Grant or award | +11,797 | 114,511 | ||
| 2024-08-26 | Silverstein Christine Berni Director | Grant or award | +11,797 | 97,471 | ||
| 2024-08-26 | Charles Faith L. Director | Grant or award | +11,797 | 113,731 |
Page 5 of 12 · 223 trades